INS and Hypoglycemia: The use of remote real-time CGM and a disposable, tubeless patch-pump with remote insulin delivery and monitoring capabilities was feasible, with a median proportion of time spent in automated mode of 95% (IQR 92%, 98%), and effective, with a mean TIR of 68% ± 16% and minimal time spent in hypoglycemia.